Your browser doesn't support javascript.
loading
MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials.
Hegi, Monika E; Genbrugge, Els; Gorlia, Thierry; Stupp, Roger; Gilbert, Mark R; Chinot, Olivier L; Nabors, L Burt; Jones, Greg; Van Criekinge, Wim; Straub, Josef; Weller, Michael.
Afiliação
  • Hegi ME; Neurosurgery & Neuroscience Research Center, Lausanne University Hospital, Lausanne, Switzerland. monika.hegi@chuv.ch.
  • Genbrugge E; European Organisation for Treatment and Research of Cancer (EORTC) Data Centre, Brussels, Belgium.
  • Gorlia T; European Organisation for Treatment and Research of Cancer (EORTC) Data Centre, Brussels, Belgium.
  • Stupp R; Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Gilbert MR; NCI, NIH, Bethesda, Maryland.
  • Chinot OL; Aix-Marseille University, AP-HM, Hôpital de la Timone, Marseille, France.
  • Nabors LB; University of Alabama at Birmingham, Birmingham, Alabama.
  • Jones G; MDxHealth, Irvine, California.
  • Van Criekinge W; Department of Mathematical Modeling, Statistics and Bio-Informatics, Ghent University, Ghent, Belgium.
  • Straub J; Merck KGaA, Darmstadt, Germany.
  • Weller M; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
Clin Cancer Res ; 25(6): 1809-1816, 2019 03 15.
Article em En | MEDLINE | ID: mdl-30514777

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Metilases de Modificação do DNA / Glioblastoma / Seleção de Pacientes / Antineoplásicos Alquilantes / Proteínas Supressoras de Tumor / Enzimas Reparadoras do DNA / Temozolomida Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Metilases de Modificação do DNA / Glioblastoma / Seleção de Pacientes / Antineoplásicos Alquilantes / Proteínas Supressoras de Tumor / Enzimas Reparadoras do DNA / Temozolomida Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article